Nothing Special   »   [go: up one dir, main page]

CN105198795B - A kind of preparation technology of lobeline hydrochloride - Google Patents

A kind of preparation technology of lobeline hydrochloride Download PDF

Info

Publication number
CN105198795B
CN105198795B CN201510659934.0A CN201510659934A CN105198795B CN 105198795 B CN105198795 B CN 105198795B CN 201510659934 A CN201510659934 A CN 201510659934A CN 105198795 B CN105198795 B CN 105198795B
Authority
CN
China
Prior art keywords
lobeline
ethyl alcohol
absolute ethyl
mtbe
butyl ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510659934.0A
Other languages
Chinese (zh)
Other versions
CN105198795A (en
Inventor
朱圣南
孙韶军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Double Crane Pharmaceutical (shangqiu) Co Ltd
Original Assignee
Double Crane Pharmaceutical (shangqiu) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Double Crane Pharmaceutical (shangqiu) Co Ltd filed Critical Double Crane Pharmaceutical (shangqiu) Co Ltd
Priority to CN201510659934.0A priority Critical patent/CN105198795B/en
Publication of CN105198795A publication Critical patent/CN105198795A/en
Application granted granted Critical
Publication of CN105198795B publication Critical patent/CN105198795B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a kind of preparation technology of lobeline hydrochloride, comprise the following steps:Under stirring, room temperature condition sequentially adds left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) into reactor, is well mixed obtained mixture a;It is 10% ~ 25% ethanol solution of hydrogen chloride that mass percent concentration is added into mixture a, then starts to be slowly heated, and heating rate is 2 ~ 4 DEG C/min, stops heating when flowing back, 0.5 ~ 2h of insulation reaction, stops stirring;Then 0 ~ 5 DEG C is cooled to, 4 ~ 6h of crystallization, filters to obtain filter cake;Filter cake is respectively washed once with methyl tertiary butyl ether(MTBE) and absolute ethyl alcohol successively, rewinding;It is forced air drying at 45 ~ 60 DEG C in temperature, it is product to obtain white crystalline powder.Yield is the method increase, reduces cost, each index of product meets Chinese 2010 editions standards of pharmacopoeia and 2015 editions standards of pharmacopoeia.

Description

A kind of preparation technology of lobeline hydrochloride
Technical field
The invention belongs to technical field of medicine synthesis, and in particular to a kind of preparation technology of lobeline hydrochloride.
Background technology
Lobeline hydrochloride is white crystals or particulate powder, odorless, bitter;The aqueous solution reacts in faintly acid.This product exists It is readily soluble in ethanol or chloroform, dissolved in water.
Lobeline hydrochloride can optionally excited chemical receptor of carotid body, excited respiratory center, heavy dose of reflectingly Also can directly excited respiratory center.Can stimulation of carotid sinus and chemoreceptor of aortic body(It is N1 acceptors), reflectivity Excited respiratory center and make accelerated breathing, but direct excitation is had no to respiratory center.Vagus nerve maincenter and blood vessel are transported Dynamic maincenter also has reflexive excitation simultaneously;It is first excited to vegetative ganglia then to block.Asphyxia neonatorum, suction fiber crops Liquor-saturated medicine and other central depressants suffocate as caused by morphine or barbitals poisoning, carbon monoxide and pneumonia, diphtheria etc. pass Catch an illness caused respiratory failure.
Use salifying method at present:Using absolute ethyl alcohol system, left-handed lobeline alkali is added into salt.Yield 65% or so, production The relevant material index of product is hardly consistent with Chinese 2010 editions pharmacopeia indexs.
The content of the invention
It is an object of the invention to provide a kind of preparation technology of lobeline hydrochloride, yield is the method increase, is reduced into This, each index of product meets Chinese 2010 editions standards of pharmacopoeia and 2015 editions standards of pharmacopoeia.
A kind of preparation technology of lobeline hydrochloride, comprises the following steps:
(1)Under stirring, room temperature condition sequentially adds left-handed lobeline, absolute ethyl alcohol and methyl tertbutyl into reactor Ether, it is well mixed obtained mixture a;The weight ratio of left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) is 1:(2~4):(6~ 12);
(2)Under stirring, first to step(1)It is 10% ~ 25% chlorination that mass percent concentration is added in obtained mixture a Hydrogen-ethanol solution, mass percent concentration are that the addition of 10% ~ 25% Hydrochlorine-Ethanol solution is the weight of left-handed lobeline 0.7 ~ 1.4 times, then start to be slowly heated, heating rate is 2 ~ 4 DEG C/min, stops heating when flowing back, and insulation is anti- 0.5 ~ 2h is answered, stops stirring;Then 0 ~ 5 DEG C is cooled to, 4 ~ 6h of crystallization, filters to obtain filter cake;
(3)By step(2)Obtained filter cake is respectively washed once with methyl tertiary butyl ether(MTBE) and absolute ethyl alcohol successively, rewinding;Yu Wen Spend for forced air drying at 45 ~ 60 DEG C, it is product to obtain white crystalline powder.
Step(1)Described in left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) weight ratio be 1:2:6.
Step(1)Described in left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) weight ratio be 1:2:8.
Step(1)Described in left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) weight ratio be 1:2:12.
Step(2)Described in Hydrochlorine-Ethanol solution mass percent concentration be 20%.
Compared with prior art, the invention has the advantages that:
For the preparation technology of lobeline hydrochloride provided by the invention compared with conventional preparation techniques, yield improves more than 30%, has Pass material list is miscellaneous, always miscellaneous reduction by 0.1%.Process is simple to operate, and product index meets 2010 editions and 2015 editions standards of pharmacopoeia, Industrialized production can be carried out.
Embodiment
With reference to specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in This.
The raw material that following examples use is commercially available prod, and the left-handed lobeline of purchase has to comply with enterprises mark It is accurate:Off-white color to light yellow solid, moisture must not exceed 0.5%, containing C22H26ClNO299.0% must not be less than, list is miscellaneous must not mistake 0.5%。
Comparative example
In the dry mouth reaction bulbs of 500mL tri-, left-handed lobeline 20g, absolute ethyl alcohol 140g are sequentially added, is added after stirring evenly 20% ethanol solution of hydrogen chloride 14g, starts to be slowly heated, and heating rate is 2 ~ 4 DEG C/min, stops heating when flowing back, and protects Temperature reaction 1h;Then 0 DEG C is cooled to, crystallization 1h, filters to obtain filter cake, filter cake cooling absolute ethyl alcohol is washed once, rewinding;In temperature For 45 ~ 60 DEG C, forced air drying 6h, white crystalline powder 14.4g is obtained, yield 64.9%, the relevant materials of HPLC are maximum single miscellaneous 0.17%, total miscellaneous 0.41%.
Embodiment 1
A kind of preparation technology of lobeline hydrochloride, comprises the following steps:
(1)Under stirring, room temperature condition sequentially adds left-handed lobeline 20g, absolute ethyl alcohol 40g and methyl- tert into reactor Butyl ether 120g, it is well mixed obtained mixture a;
(2)Under stirring, first to step(1)It is 20% hydrogen chloride-second that mass percent concentration is added in obtained mixture a Alcoholic solution 14g, then start to be slowly heated, heating rate is 2 ~ 4 DEG C/min, stops heating, insulation reaction when flowing back 1h, stop stirring;Then 0 ~ 5 DEG C is cooled to, 4 ~ 6h of crystallization, filters to obtain filter cake;
(3)By step(2)Obtained filter cake is respectively washed once with methyl tertiary butyl ether(MTBE) and absolute ethyl alcohol successively, rewinding;Yu Wen Spend for forced air drying at 45 ~ 60 DEG C, it is product to obtain white crystalline powder.
The white crystalline powder 21.2g that the present embodiment obtains, yield 95.5%, the relevant materials of HPLC are maximum single miscellaneous 0.13%, total miscellaneous 0.28%.
Embodiment 2
A kind of preparation technology of lobeline hydrochloride, comprises the following steps:
(2)Under stirring, room temperature condition sequentially adds left-handed lobeline 20g, absolute ethyl alcohol 40g and methyl- tert into reactor Butyl ether 160g, it is well mixed obtained mixture a;
(2)Under stirring, first to step(1)It is 20% hydrogen chloride-second that mass percent concentration is added in obtained mixture a Alcoholic solution 14g, then start to be slowly heated, heating rate is 2 ~ 4 DEG C/min, stops heating, insulation reaction when flowing back 1h, stop stirring;Then 0 ~ 5 DEG C is cooled to, 4 ~ 6h of crystallization, filters to obtain filter cake;
(4)By step(2)Obtained filter cake is respectively washed once with methyl tertiary butyl ether(MTBE) and absolute ethyl alcohol successively, rewinding;Yu Wen Spend for forced air drying at 45 ~ 60 DEG C, it is product to obtain white crystalline powder.
The white crystalline powder 21.3g that the present embodiment obtains, yield 95.9%, the relevant materials of HPLC are maximum single miscellaneous 0.12%, total miscellaneous 0.27%.
Embodiment 3
A kind of preparation technology of lobeline hydrochloride, comprises the following steps:
(3)Under stirring, room temperature condition sequentially adds left-handed lobeline 20g, absolute ethyl alcohol 40g and methyl- tert into reactor Butyl ether 240g, it is well mixed obtained mixture a;
(2)Under stirring, first to step(1)It is 20% hydrogen chloride-second that mass percent concentration is added in obtained mixture a Alcoholic solution 14g, then start to be slowly heated, heating rate is 2 ~ 4 DEG C/min, stops heating, insulation reaction when flowing back 1h, stop stirring;Then 0 ~ 5 DEG C is cooled to, 4 ~ 6h of crystallization, filters to obtain filter cake;
(5)By step(2)Obtained filter cake is respectively washed once with methyl tertiary butyl ether(MTBE) and absolute ethyl alcohol successively, rewinding;Yu Wen Spend for forced air drying at 45 ~ 60 DEG C, it is product to obtain white crystalline powder.
The white crystalline powder 21.3g that the present embodiment obtains, yield 95.9%, the relevant materials of HPLC are maximum single miscellaneous 0.09%, total miscellaneous 0.29%.

Claims (5)

1. a kind of preparation technology of lobeline hydrochloride, it is characterised in that comprise the following steps:
(1)Under stirring, room temperature condition sequentially adds left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) into reactor, mixes Close uniformly obtained mixture a;The weight ratio of left-handed lobeline, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) is 1:(2~4):(6~12);
(2)Under stirring, first to step(1)It is 10% ~ 25% hydrogen chloride-second that mass percent concentration is added in obtained mixture a Alcoholic solution, mass percent concentration be 10% ~ 25% Hydrochlorine-Ethanol solution addition for left-handed lobeline weight 0.7 ~ 1.4 times, then starting to be slowly heated, heating rate is 2 ~ 4 DEG C/min, stops heating up when flowing back, insulation reaction 0.5 ~ 2h, stop stirring;Then 0 ~ 5 DEG C is cooled to, 4 ~ 6h of crystallization, filters to obtain filter cake;
(3)By step(2)Obtained filter cake is respectively washed once with methyl tertiary butyl ether(MTBE) and absolute ethyl alcohol successively, rewinding;It is in temperature Forced air drying at 45 ~ 60 DEG C, it is product to obtain white crystalline powder.
2. the preparation technology of lobeline hydrochloride according to claim 1, it is characterised in that:Step(1)Described in left-handed Lip river The weight ratio of Belling, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) is 1:2:6.
3. the preparation technology of lobeline hydrochloride according to claim 1, it is characterised in that:Step(1)Described in left-handed Lip river The weight ratio of Belling, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) is 1:2:8.
4. the preparation technology of lobeline hydrochloride according to claim 1, it is characterised in that:Step(1)Described in left-handed Lip river The weight ratio of Belling, absolute ethyl alcohol and methyl tertiary butyl ether(MTBE) is 1:2:12.
5. the preparation technology of lobeline hydrochloride according to claim 1, it is characterised in that:Step(2)Described in hydrogen chloride- The mass percent concentration of ethanol solution is 20%.
CN201510659934.0A 2015-10-14 2015-10-14 A kind of preparation technology of lobeline hydrochloride Active CN105198795B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510659934.0A CN105198795B (en) 2015-10-14 2015-10-14 A kind of preparation technology of lobeline hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510659934.0A CN105198795B (en) 2015-10-14 2015-10-14 A kind of preparation technology of lobeline hydrochloride

Publications (2)

Publication Number Publication Date
CN105198795A CN105198795A (en) 2015-12-30
CN105198795B true CN105198795B (en) 2017-11-21

Family

ID=54946795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510659934.0A Active CN105198795B (en) 2015-10-14 2015-10-14 A kind of preparation technology of lobeline hydrochloride

Country Status (1)

Country Link
CN (1) CN105198795B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113981020B (en) * 2021-12-10 2024-09-10 江苏恒盛药业有限公司 Method for synthesizing lobelin hydrochloride intermediate by enzyme catalytic chiral reduction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004034682A1 (en) * 2004-07-17 2006-02-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Shortened process for the preparation of chiral lobeline

Also Published As

Publication number Publication date
CN105198795A (en) 2015-12-30

Similar Documents

Publication Publication Date Title
EP3328831B1 (en) A method for preparing methyl (z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene)-oxindole-6-carboxylate (intedanib, nintedanib)
CN106188116A (en) A kind of method of synthesizing pyrazole 4 boric acid pinacol ester
CN107033212A (en) A kind of ursolic acid derivative with anti-inflammatory activity and its production and use
CN106431969B (en) A kind of method for preparing 2- methyl -4- formaldoxime yl benzoic acid methyl esters
CN105198795B (en) A kind of preparation technology of lobeline hydrochloride
CN104418804B (en) A kind of celecoxib impurity and preparation method thereof, application
CN102351790B (en) Method for synthesizing 7-bromo-6-chloro-4-quinazolinone
CN106279175A (en) A kind of preparation method of Ertapenem Sodium
CN103896940B (en) A kind of synthetic method of Eliquis
CN101108824B (en) Method for synthesizing 2- chlorine -3- cyanogen radical pyridine with 3- cyanogen radical pyridine
CN108148070A (en) A kind of synthetic method of furanone and compound of isobioquin group
CN112898307A (en) Ketorolac impurity C and preparation method and application thereof
CN103588765A (en) Synthesis method for azilsartan medoxomil or salt thereof, intermediate of azilsartan medoxomil or salt thereof and synthesis method for intermediate
CN104387284B (en) Synthesis methods of D9-clenbuterol hydrochloride labeled by deuterium and synthesis intermediate thereof
CN103508898B (en) A kind of preparation method of new alverine citrate
CN102153518B (en) Preparation method of Gefitinib
KR101406736B1 (en) Agomelatine hydrobromide hydrate and preparation thereof
CN103833741A (en) Emtricitabine salicylate and preparation method and application thereof
CN107001284A (en) A kind of crystal form of androgen receptor inhibitor and preparation method thereof
CN113045475A (en) Preparation method of 5-bromo-7-methylindole
CN105153167A (en) Ticagrelor crystal and medicinal composition comprising same
CN108558676B (en) Preparation method of N, N-dibenzylethylenediamine diacetate
CN112759590B (en) Preparation method of moxifloxacin
CN104250213B (en) A kind of preparation method of (E)-2-(2 '-chloromethyl) phenyl-3-methoxy-methyl acrylate
CN103408495A (en) Synthesis process of phentolamine mesilate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Zhu Shengnan

Inventor after: Sun Shaojun

Inventor before: Zhu Shengnan

Inventor before: Sun Shaojun

COR Change of bibliographic data
GR01 Patent grant
GR01 Patent grant